FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

420736004: Conventional release eye suspension (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2616717019 Eye suspension en Synonym Active Entire term case insensitive SNOMED CT core module
2673151016 Ophthalmic suspension en Synonym Active Entire term case insensitive SNOMED CT core module
3620934010 Conventional release eye suspension (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620935011 Conventional release eye suspension en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release eye suspension Is a Drug suspension false Inferred relationship Existential restriction modifier
Conventional release eye suspension Is a Ocular dose form true Inferred relationship Existential restriction modifier
Conventional release eye suspension Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release eye suspension Has dose form intended site Ocular true Inferred relationship Existential restriction modifier
Conventional release eye suspension Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release eye suspension Has basic dose form Suspension true Inferred relationship Existential restriction modifier
Conventional release eye suspension Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Conventional release suspension for eye drops Is a False Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension Has manufactured dose form False Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form False Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Levobetaxolol hydrochloride 0.5% ophthalmic suspension Has manufactured dose form False Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Prednisolone acetate 25mg/mL suspension Has manufactured dose form False Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely prednisolone acetate 1.25 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely medrysone 10 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Tetracycline hydrochloride 1%wv suspension Has manufactured dose form False Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone 500 microgram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely besifloxacin 6 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely difluprednate 500 microgram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely levobetaxolol 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form False Conventional release eye suspension Inferred relationship Existential restriction modifier
Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) Has manufactured dose form True Conventional release eye suspension Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start